Percentage of adult patients aged 25 and older with atrial fibrillation and major stroke risk factors who are on anticoagulation therapy.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Patients with evidence of anticoagulation therapy.
DenominatorAll patients with Atrial Fibrillation and one of the following:
1. Age greater than or equal to 25 with prior stroke, mitral stenosis or mitral valve replacement
2. Age greater than or equal to 75 and 1 of the following: diabetes, hypertension or CHF
3. Age less than 75 and 2 of the following: diabetes, hypertension or CHFExclusionsContraindications to warfarin, including:
• Esophageal varices with bleed
• Aortic dissection
• Intracerebral hemorrhage
• Blood transfusion(RBC or platelets)
• Severe brain injury
• Dementia
• Alcohol use/abuse
• Falls
• Fracture
• Hemorrhage contraindications and procedures
• Adverse effects fromcoumadin
• Abnormal gait/incoordination
• Neuro and eye surgery
• Gastritis with Current fill of Proton pump inhibitors
• Thrombocytopenia
• Hematocrit lab value < 25
• Pregnancy
• Patient or provider feedback indicating patient has allergy, intolerance, or contraindication to the drug anytime in the past
• General exclusions:
Terminal illness anytime in the past
hospice in the past 12 months
- Measure StructureClinical Condition Topic AreaTarget PopulationNational Quality Strategy PrioritiesPrevention and Treatment
- Risk Adjustment
- Current or planned use(s)
- Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative DataInitial EndorsementEndorsement StatusLast UpdatedRemoval Date
- StewardSteward Organization Email